ORLACCHIO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 13.134
EU - Europa 10.390
AS - Asia 9.481
SA - Sud America 1.689
AF - Africa 223
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 7
Totale 34.943
Nazione #
US - Stati Uniti d'America 12.893
SG - Singapore 4.103
UA - Ucraina 2.499
IE - Irlanda 1.685
RU - Federazione Russa 1.426
SE - Svezia 1.367
VN - Vietnam 1.332
BR - Brasile 1.296
HK - Hong Kong 1.246
CN - Cina 1.125
FR - Francia 731
DE - Germania 677
IT - Italia 603
FI - Finlandia 565
KR - Corea 421
GB - Regno Unito 357
TR - Turchia 294
IN - India 210
AR - Argentina 136
BD - Bangladesh 123
CA - Canada 105
IQ - Iraq 99
PL - Polonia 94
MX - Messico 87
PK - Pakistan 75
ZA - Sudafrica 70
UZ - Uzbekistan 68
CO - Colombia 67
NL - Olanda 65
CH - Svizzera 63
JP - Giappone 58
EC - Ecuador 55
AT - Austria 47
ID - Indonesia 44
SA - Arabia Saudita 42
ES - Italia 38
VE - Venezuela 38
MA - Marocco 32
PH - Filippine 32
BE - Belgio 31
LB - Libano 31
KE - Kenya 29
CZ - Repubblica Ceca 26
AE - Emirati Arabi Uniti 24
CL - Cile 24
PY - Paraguay 23
TN - Tunisia 21
JO - Giordania 20
LT - Lituania 19
BO - Bolivia 18
MY - Malesia 17
RO - Romania 17
EG - Egitto 16
EU - Europa 15
PE - Perù 14
SK - Slovacchia (Repubblica Slovacca) 14
UY - Uruguay 14
AZ - Azerbaigian 13
JM - Giamaica 13
OM - Oman 13
TH - Thailandia 13
GR - Grecia 12
IL - Israele 10
NP - Nepal 10
DK - Danimarca 9
ET - Etiopia 9
PS - Palestinian Territory 9
KG - Kirghizistan 8
KZ - Kazakistan 8
QA - Qatar 8
CI - Costa d'Avorio 7
CR - Costa Rica 7
DZ - Algeria 7
PT - Portogallo 7
AL - Albania 6
HN - Honduras 6
NG - Nigeria 6
NI - Nicaragua 6
BH - Bahrain 5
HU - Ungheria 5
AU - Australia 4
BY - Bielorussia 4
CY - Cipro 4
ML - Mali 4
PA - Panama 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
GE - Georgia 3
GY - Guiana 3
IR - Iran 3
LY - Libia 3
MD - Moldavia 3
MK - Macedonia 3
MU - Mauritius 3
NO - Norvegia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 34.904
Città #
Singapore 2.669
Chandler 1.710
Dublin 1.685
Jacksonville 1.427
Hong Kong 1.243
San Jose 1.206
San Mateo 976
Dong Ket 800
Ashburn 726
Boardman 593
Moscow 532
Santa Clara 499
Seoul 417
Medford 416
Princeton 414
Lauterbourg 365
Wilmington 360
Beijing 246
Ann Arbor 233
Izmir 221
Ho Chi Minh City 219
Andover 213
Perugia 186
Des Moines 176
Piscataway 175
Los Angeles 173
Saint Petersburg 135
São Paulo 133
New York 129
Helsinki 125
Hanoi 114
Altamura 112
Munich 106
The Dalles 102
Shanghai 98
Lawrence 86
Philadelphia 82
Norwalk 74
Woodbridge 72
Tokyo 56
Warsaw 53
Dallas 47
Frankfurt am Main 47
Brooklyn 45
Chennai 45
Council Bluffs 45
Johannesburg 44
Montreal 44
Orem 44
Auburn Hills 42
Baghdad 40
London 40
Stockholm 38
Atlanta 36
Tashkent 36
Amsterdam 35
Houston 34
Redmond 34
Belo Horizonte 33
San Francisco 31
Brussels 30
Columbus 30
Chicago 29
Denver 29
Nuremberg 28
Rio de Janeiro 28
Lahore 26
Mexico City 26
Turku 26
Falls Church 25
Medellín 24
Porto Alegre 24
Manchester 23
Mumbai 23
Nairobi 23
Poplar 23
Toronto 23
Haiphong 22
Boston 21
Rome 21
Dhaka 20
San Paolo di Civitate 20
Secaucus 20
Turin 20
Brasília 19
Da Nang 19
Den Haag 19
Milan 19
San Diego 19
Ankara 18
Jeddah 18
Vienna 18
Amman 17
Falkenstein 17
Buenos Aires 16
Campinas 16
Quito 16
Zhengzhou 16
Guarulhos 15
Karachi 15
Totale 20.978
Nome #
a-C:H NANOPATTERNED FILM DESIGNS DRIVE HUMAN BONE MARROW MESENCHYMAL STEM CELL CYTOSKELETON ARCHITECTURE 166
Caspase 3 mediated PARP cleavage in lymphocytes from newborn babies of diabetic mothers 155
a-D-Mannosidses in patients with familial Alzheimer's Disease 154
Cathepsin D expression and processing in fibroblasts from Alzheimer's disease patients 144
Targeted disruption of the lysosomal alpha-mannosidase gene results in mice resembling the phenotype of human alpha-mannosidosis 143
B-Hexosaminidase, a-D-Mannosidase and B-Mannosidase expression in: Serum and leukocites patients with carbohydrate deficient glycoprotein syndrome type I 143
a-D-Mannosidases in patients with Alzheimer's disease 141
"BIOCHIMICA" Campbell Farrell 141
Carbon nanotubes and silver nanoparticles for multifunctional conductive polymer composites 141
Beta-Hexosaminidase, alpha-D-mannosidase and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 137
Adenoviral and AAV vectors for an efficient intracerebral gene transfer in the Sandhoff mouse model 135
Absence of metabolic cross-correction in tay-sachs cells: implication in gene therapy 135
b-Hexosaminidase and altered cell-mediated immuno-responce 134
beta-hexosaminidase over-expression affects glycosphingolipid metabolism in mammalian cells-52° Congresso SIB 133
Implication of Cathepsins S and D in TPO+IL-16-induced commitment of hematopoietic stem cell differentiation into tolerogenic dendritic cells 133
Beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 132
Promoter characterization and structure of the gene econding mouse sulphamidase 131
Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. 131
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. 131
A distinct beta-hexosaminidase isoenzyme separated from human leukemic lymphocytes and myelocytes 131
A calcium requirement for the phosphatidylinositol response floowing activation of presynaptic muscarinic receptors. 128
A coupled assay for UDP-GlcNAc:Galβ1-3GalNAc-R β1,6-N-acetylglucosaminyltransferase (GlcNAc to GalNAc) 126
Adult neural stem cells as a tool for gehe therapy of Tay-Sachs disease 125
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 125
Generation of a chitobiase knock out mouse model 125
Assignment of lysosomal alpha-D-mannosidase to mouse chromosome 8. 125
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 125
Expression of lysosomal proteases cathepsin D, B and L in fibroblasts from Alzheimer's disease patients 124
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 124
Age related and lectin influenced changes of exoglycosidases activity in cultured chick embryonic skin fibroblasts. 124
beta-hexosaminidase, alpha-D-mannosidase and beta-mannosidase expression in serum and Ieukocytes from patients with Carbohydrate-deficient glycoprotein syndrome type 1 123
An approach for fluorometric determination of glycosyltransferase activities 123
Amphotericin B stimulates secretion of β-hexosaminidase from mouse adherent spleen cells 123
Beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 123
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 123
B-D-Mannosidase: Towards a mouse model of B-Mannosidosis 122
Cellule staminali e GM2 gangliosidosi 121
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 121
Approcci di terapia genica per le malattie da accumulo metabolico lisosomiale con coinvolgimento neurologico 120
Human bone marrow mesenchymal stem cell guidance by a-C:H surface designes 120
Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPS 120
Identificazione di sequenze peptidiche capaci di mimare carboidrati 119
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 119
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 119
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 118
Influence of cell differentiation and protein kinase C activation on sub-cellular distribution of beta-N-acetylhexosaminidases of HL 60 cells. 118
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 118
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 117
B-hexosaminidase isoenzymes and antigen presenting cell function: implication for neurodegenerative process in GM2-gangliosidosis 117
Localizzazione e caratterizzazione biochimica di forma di membrana nella b-n-acetilesosaminidase 116
Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. 116
Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases 116
Differential regulation of lysosomal enzymes in fibroblasts from Alzheimer's disease patients 115
Analysis of the patterns of expression of mRNAs for the alpha-and beta-subunits of the lysosomal enzyme beta-N-acetylhexosaminidase in mouse epididymis and testis. 115
Distinct alpha-L-fucosidase isoenzyme profiles in human leukemic cells. 115
Hydrogenated Amorphous Carbon Nanopatterned Film Designs Drive Human Bone Marrow Mesenchymal Stem Cell Cytoskeleton Architecture 115
Human plasma membrane associated B-hexosaminidase A Hydrolizes GM2 ganglioside 114
Constitutive expression of beta-N-acetylhexosaminidase in a microglial cell line: transcriptional modulation by lipopolysaccharide and serum factors 114
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 114
MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM CELLS TOWARDS NEURONAL DIFFERENTIATION 114
Unusual molecular weight forms of N-acetyl-beta-D-hexosaminidase from intestinal mucosa of newborn pigs 114
The biology of cupressaceae allergy II. Biochemical and immunological identification of the native major allergen as B-galactosidase 113
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 113
a-C:H nanopatterned grooves influence human bone marrow stromal stem cells orientation 113
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 113
Development of a New Tool for 3D Modeling for Regenarative Medicine 113
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 113
Molecular cytogenetic analysis of the 5Q-chromosome in the HL60 cell-line and in the 5Q-Syndrome 112
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 112
Absence of Association between APOA1 Polymorphism and Alzheimer disease 112
Analysis of galactocerebrosidase activity in the mouse brain by a-new hysological staining method 112
Cloning of human MENA gene 111
Effect of ascorbic acid on lysosomal hydrolases and beta-APP processing in Alzheimer's disease fibroblasts 111
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 110
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 110
Carbon nanotubes and silver nanoparticles for multifunctional conductive biopolymer composites 110
Gm2 activator protein expression in mouse tissues 110
Expression of human a-subunit gene in the central nervous system of the Tay-Sachs animal model 109
Espressione di glicoidrolasi acide nella malattia di Alzheimer 109
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 109
4-METHYLUMBELLIFERYL-ß-N-ACETYLGLUCOSAMINE-6-SULPHATE FOR CARRIER DETECTION OF TAY-SACHS DISEASE 109
Restoration of hexosaminidase A activity and GM2 ganglioside metabolism in cells from patients with Tay-Sachs Disease 108
Glycohydrolase expression in Alzheimer disease 108
Association study of the 5-HT6 receptor gene in Alzheimer's disease 108
Ras differentially regulates lysosomal enzymes expression 108
"Terapia delle malattie neurodegenerative con cellule staminali: overview sullo stato attuale" 108
beta-Hexosaminidase expression in chick embryo fibroblasts in vitro. 108
Lysosomal proteases cathepsin D, B, and L are down-regulated in fibroblasts from Alzheimer's disease patients 107
Immunoblotting characterization of CA 125 in biological fluids:difference between pregnancy and cancer CA 125 origin. 107
Beta-Hexosaminidase expression is recapitulated in Neural Stem Cells induced to differentiate and in embryonic to adult brain development in both WT and knock-out mice 107
Absence of association between APOA1 polymorphism and Alzheimer's disease. 107
An enzyme with properties similar to those of Beta-N-acetylhexosaminidase S is espressed in the promyelocytic cell line HL-60. 107
Beta-Hexosaminidase and immuno-response: implications for the neurodegenerative process in GM2 gangliosidosis 106
Identification of plasma membrane associated mature B-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts 106
On inhibitors of pyridoxal-phosphate-dependent enzymes. Synthesis and properties of some pyridoxal derivatives. 106
Characterization of hMENA gene 105
Human sulphamidase gene promoter characterization and tissue distribution 105
Calcium ionophore A-23187 inhibits the secretion of β-hexosaminidase from the GG2EE mouse macrophage cell line 105
Tuning multi pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats. 105
Targeted disruption of the mouse lysosomal a-D-mannosidase gene 104
Totale 11.953
Categoria #
all - tutte 149.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021878 0 0 0 0 0 0 0 0 0 0 0 878
2021/20223.338 80 675 129 223 122 23 20 1.059 22 80 382 523
2022/20235.297 457 509 115 417 497 650 20 248 2.144 3 176 61
2023/20242.143 176 248 110 25 22 16 375 121 371 62 251 366
2024/20255.117 42 594 176 181 679 199 339 274 1.029 294 932 378
2025/202610.818 872 719 572 1.625 1.419 988 1.695 454 1.350 896 186 42
Totale 35.689